Panadeekarn Panjawatanan
Overview
Explore the profile of Panadeekarn Panjawatanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wijarnpreecha K, Panjawatanan P, Cheungpasitporn W, Lukens F, Harnois D, Pungpapong S, et al.
J Gastrointestin Liver Dis
. 2020 Jun;
29(2):211-217.
PMID: 32530988
Background And Aims: Recent studies have suggested an association between periodontitis and nonalcoholic fatty liver disease (NAFLD) although the results were inconsistent. The current systematic review and meta- analysis was...
12.
Wijarnpreecha K, Aby E, Panjawatanan P, Kroner P, Harnois D, Palmer W, et al.
Eur J Gastroenterol Hepatol
. 2020 Mar;
33(1):96-101.
PMID: 32118852
Background/objectives: Arthritis is a known manifestation of hereditary hemochromatosis. However, whether patients with hereditary hemochromatosis have an increased risk of having joint replacement surgery compared to the general population is...
13.
Panjawatanan P, Wijarnpreecha K, Kim D
Transl Gastroenterol Hepatol
. 2019 Dec;
4:77.
PMID: 31872141
No abstract available.
14.
Wijarnpreecha K, Panjawatanan P, Thongprayoon C, Ungprasert P
Indian J Med Res
. 2019 Dec;
150(4):359-364.
PMID: 31823917
Background & Objectives: Clostridium difficile infection is one of the most common healthcare-associated infections worldwide. Recent epidemiologic studies have suggested that statin users may have a lower risk of C....
15.
Abid H, Khavandi M, Siddiqui N, Panjawatanan P, Patel A
Cureus
. 2019 Dec;
11(10):e5997.
PMID: 31807385
Thyroid dysfunction is one of the major side effects associated with Pembrolizumab in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). We performed a systematic review and...
16.
Wijarnpreecha K, Werlang M, Watthanasuntorn K, Panjawatanan P, Cheungpasitporn W, Gomez V, et al.
Dig Dis Sci
. 2019 Oct;
65(5):1414-1422.
PMID: 31605277
Background/objectives: Recent studies have proposed that obesity may be associated with a higher risk of small intestine bacterial overgrowth (SIBO) although the results were inconsistent. The microbiome has a known...
17.
Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner P, Cheungpasitporn W, Lukens F, et al.
Ann Hepatol
. 2019 Aug;
19(3):245-250.
PMID: 31422030
Studies have suggested that the presence of sarcopenia in patients with cirrhosis could be a predisposing risk factor for hepatic encephalopathy. This systematic review and meta-analysis were conducted to summarize...
18.
Wijarnpreecha K, Panjawatanan P, Corral J, Lukens F, Ungprasert P
J Evid Based Med
. 2019 Jun;
12(3):194-199.
PMID: 31218829
Background/objectives: Several epidemiologic studies have suggested that patients with celiac disease may be at an increased risk of sarcoidosis but the results were inconsistent. This systematic review and meta-analysis was...
19.
Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner P, Mousa O, Pungpapong S, et al.
J Gastrointestin Liver Dis
. 2019 Jun;
28:197-203.
PMID: 31204401
Background And Aims: Studies have suggested that smokers may have a higher risk of primary biliary cholangitis (PBC) although the results have been inconsistent. This systematic review and meta-analysis aim...
20.
Wijarnpreecha K, Panjawatanan P, Aby E, Ahmed A, Kim D
Maturitas
. 2019 May;
124:48-54.
PMID: 31097179
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children and adults of all ethnicities. NAFLD is commonly seen in individuals with metabolic abnormalities,...